Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.

Wu X, Xia T, Cao M, Zhang P, Shi G, Chen L, Zhang J, Yin J, Wu P, Cai B, Lu Z, Miao Y, Jiang K.

Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819887962. doi: 10.1177/1533033819887962.

2.

Diabetes and Younger Age Are Vital and Independent Risk Factors for Acute Pancreatitis in Patients with Severe Hypertriglyceridemia.

Li Q, Hou C, Peng Y, Zhu X, Shi C, Zhang K, Tu M, Guo F, Huang D, Miao Y.

Biomed Res Int. 2019 Oct 13;2019:2620750. doi: 10.1155/2019/2620750. eCollection 2019.

3.

Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.

Dai S, Peng Y, Zhu Y, Xu D, Zhu F, Xu W, Chen Q, Zhu X, Liu T, Hou C, Wu J, Miao Y.

Biomed Pharmacother. 2020 Jan;121:109521. doi: 10.1016/j.biopha.2019.109521. Epub 2019 Nov 2.

4.

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.

Xu-Monette ZY, Li J, Xia Y, Crossley B, Bremel RD, Miao Y, Xiao M, Snyder T, Manyam GC, Tan X, Zhang H, Visco C, Tzankov A, Dybkaer K, Bhagat G, Tam W, You H, Hsi ED, van Krieken JH, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Winter JN, Medeiros JT, Xu B, Li Y, Kirsch I, Young KH.

J Immunother Cancer. 2019 Oct 22;7(1):272. doi: 10.1186/s40425-019-0730-x.

5.

Minimally invasive drainage versus open surgical debridement in SAP/SMAP - a network meta-analysis.

Zhang K, Zhu X, Hou C, Shi C, Miao Y, Li Q.

BMC Gastroenterol. 2019 Oct 21;19(1):168. doi: 10.1186/s12876-019-1078-x.

6.

YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways.

Chen Q, Yang C, Chen L, Zhang JJ, Ge WL, Yuan H, Meng LD, Huang XM, Shen P, Miao Y, Jiang KR.

Br J Cancer. 2019 Nov;121(11):912-921. doi: 10.1038/s41416-019-0604-5. Epub 2019 Oct 21.

7.

The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.

Xia T, Wu X, Cao M, Zhang P, Shi G, Zhang J, Lu Z, Wu P, Cai B, Miao Y, Jiang K.

Pathol Res Pract. 2019 Nov;215(11):152666. doi: 10.1016/j.prp.2019.152666. Epub 2019 Sep 24.

PMID:
31606241
8.

Parenchyma Preserving Surgery for Idiopathic Chronic Calcific Pancreatitis in Children: A Report of Three Cases.

Wolde TG, Cai B, Feng G, Wu J, Gao W, Wei J, Miao Y.

J Pancreat Cancer. 2019 Oct 3;5(1):51-57. doi: 10.1089/pancan.2019.0008. eCollection 2019.

9.

Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-κB pathway.

Hou C, Zhu X, Shi C, Peng Y, Huang D, Li Q, Miao Y.

Biomed Pharmacother. 2019 Nov;119:109455. doi: 10.1016/j.biopha.2019.109455. Epub 2019 Sep 18.

10.

YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER/STAT3/MMP2 signaling pathway.

Chen Q, Zhang JJ, Ge WL, Chen L, Yuan H, Meng LD, Huang XM, Shen P, Miao Y, Jiang KR.

Cancer Lett. 2019 Oct 28;463:37-49. doi: 10.1016/j.canlet.2019.07.019. Epub 2019 Aug 9.

11.

CT-guided percutaneous catheter drainage of pancreatic postoperative collections.

Liu T, Sun S, Gao H, Gao Y, Xu Q, Liu X, Miao Y, Wei J.

Minim Invasive Ther Allied Technol. 2019 Jul 13:1-6. doi: 10.1080/13645706.2019.1641524. [Epub ahead of print]

PMID:
31304803
12.

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P.

JCI Insight. 2019 Jun 25;5. pii: 127552. doi: 10.1172/jci.insight.127552.

13.

SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients.

Miao Y, Zou YX, Gu DL, Zhu HC, Zhu HY, Wang L, Liang JH, Xia Y, Wu JZ, Shao CL, Fan L, Zhang Z, Xu W, Li JY.

Ann Transl Med. 2019 Apr;7(8):176. doi: 10.21037/atm.2019.03.63.

14.

Genetic alterations and their clinical implications in DLBCL.

Miao Y, Medeiros LJ, Li Y, Li J, Young KH.

Nat Rev Clin Oncol. 2019 Oct;16(10):634-652. doi: 10.1038/s41571-019-0225-1. Review.

PMID:
31127191
15.

Topological control of cytokine receptor signaling induces differential effects in hematopoiesis.

Mohan K, Ueda G, Kim AR, Jude KM, Fallas JA, Guo Y, Hafer M, Miao Y, Saxton RA, Piehler J, Sankaran VG, Baker D, Garcia KC.

Science. 2019 May 24;364(6442). pii: eaav7532. doi: 10.1126/science.aav7532. Epub 2019 May 23.

PMID:
31123111
16.

Glycyrrhizin protects human melanocytes from H2O2‑induced oxidative damage via the Nrf2‑dependent induction of HO‑1.

Mou K, Pan W, Han D, Wen X, Cao F, Miao Y, Li P.

Int J Mol Med. 2019 Jul;44(1):253-261. doi: 10.3892/ijmm.2019.4200. Epub 2019 May 16.

17.

Lung adenocarcinoma metastasis to pancreas after the absence of primary tumour for almost two years.

Shadhu K, Xi C, Wei J, Miao Y.

JRSM Open. 2019 May 8;10(5):2054270419850498. doi: 10.1177/2054270419850498. eCollection 2019 May.

18.

Receptor subtype discrimination using extensive shape complementary designed interfaces.

Dang LT, Miao Y, Ha A, Yuki K, Park K, Janda CY, Jude KM, Mohan K, Ha N, Vallon M, Yuan J, Vilches-Moure JG, Kuo CJ, Garcia KC, Baker D.

Nat Struct Mol Biol. 2019 Jun;26(6):407-414. doi: 10.1038/s41594-019-0224-z. Epub 2019 May 13.

19.

Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.

Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W, Miao Y.

Cancer Med. 2019 Jun;8(6):2810-2822. doi: 10.1002/cam4.2145. Epub 2019 Apr 21.

20.

Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death.

Liu X, Huang Y, Yuan H, Qi X, Manjunath Y, Avella D, Kaifi JT, Miao Y, Li M, Jiang K, Li G.

Cancer Lett. 2019 Jul 10;454:204-214. doi: 10.1016/j.canlet.2019.04.022. Epub 2019 Apr 17.

PMID:
31004701

Supplemental Content

Loading ...
Support Center